Evidence map›Paper›PMID 42853878›Full record

ArticlePloS one2026

Correlation analysis between preoperative inflammation-nutrition-related indices and the risk of pancreatic fistula formation following distal pancreatectomy.

Shiwei Wu, Dongxing Zhang, Yizhang Zhu, Ning Li, Daobin Wang, Jiayue Zou, Xiaoyuan Hu, Jiawei Jin, Jun He, Xiaofeng Xue and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shiwei WuPancreatic Disease Center, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.ORCID https://orcid.org/0009-0002-8604-9130
Dongxing ZhangPancreatic Disease Center, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Yizhang ZhuDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Ning LiDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Daobin WangPancreatic Disease Center, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Jiayue ZouPancreatic Disease Center, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Xiaoyuan HuPancreatic Disease Center, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Jiawei JinDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Jun HePancreatic Disease Center, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Xiaofeng XuePancreatic Disease Center, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Lei QinPancreatic Disease Center, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.ORCID https://orcid.org/0009-0000-8339-3855

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the associations of preoperative C-reactive protein-to-albumin ratio (CAR), inflammatory burden index (IBI), and C-reactive protein-albumin-lymphocyte (CALLY) index with clinically relevant postoperative pancreatic fistula (CR-POPF) after distal pancreatectomy (DP), and to compare their predictive value, providing a reference for preoperative risk assessment.

methodsWe retrospectively included 300 patients who underwent DP between June 2022 and June 2024. CR-POPF was defined according to the 2016 International Study Group of Pancreatic Surgery (ISGPS) criteria as Grade B or Grade C POPF. Multivariable logistic regression was used to evaluate the associations of CAR, IBI, and CALLY with CR-POPF, and restricted cubic splines were used to assess dose-response relationships. Predictive performance of the preoperative baseline model and models incorporating each index was compared using receiver operating characteristic (ROC) analysis with DeLong tests, calibration assessment, Brier scores, decision curve analysis, and 1,000-resample bootstrap internal validation.

resultsCR-POPF occurred in 84 of 300 patients (28.0%); among these events, 81 (96.4%) were Grade B and 3 (3.6%) were Grade C. In preoperative-adjusted analyses, higher CAR (odds ratio [OR] 230.244, 95% confidence interval [CI] 45.053-1176.652; P < 0.001) and IBI (OR 1.015, 95% CI 1.006-1.024; P < 0.001) were associated with higher odds of CR-POPF, whereas higher CALLY was associated with lower odds (OR 0.979, 95% CI 0.967-0.991; P = 0.001). The baseline model had an area under the ROC curve (AUC) of 0.786 (95% CI 0.726-0.845). Adding CAR increased the AUC to 0.894 (95% CI 0.857-0.931; P < 0.001 vs baseline), compared with 0.821 for IBI (P = 0.004) and 0.827 for CALLY (P = 0.016). Bootstrap-corrected AUCs were 0.763 for the baseline model, 0.879 for baseline+CAR, 0.796 for baseline+IBI, and 0.805 for baseline+CALLY. The CAR-extended model also had the lowest Brier score (0.120) and showed the greatest net benefit across much of the examined threshold range.

conclusionsPreoperative CAR, IBI, and CALLY were associated with CR-POPF after DP. Among the three indices, CAR showed the strongest predictive performance when added to the preoperative clinical model. These findings may provide a reference for preoperative risk assessment, although external validation is needed.

Indexed as

InflammationPancreatectomyPancreatic FistulaPostoperative ComplicationsAgedC-Reactive ProteinFemaleHumansMaleMiddle AgedNutritional StatusPreoperative PeriodRetrospective StudiesRisk AssessmentRisk FactorsROC CurveC-Reactive ProteinSerum Albumin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.